PERCHERON THERAPEUTICS LIMITED
ASX:PERPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 79.4% of what they think they own, once every option and right converts.
Share count grew 89% in 24 months; runway 2–4 quarters; 2 cash raises in 24 months
Percheron Therapeutics' share count as at October 2026 stood at 1.98B shares from the ASX market reading; the filed Appendix 2A series ends earlier, so the percentage change over that window is not stated. The company raised capital twice in the past 24 months for total proceeds of A$4.5M, most recently a A$2.3M placement in September 2026. Options on issue could convert into 514M new shares, representing an overhang of 25.9% of the current share count; none are in the money, and the nearest expiry is April 2028. The company had 2 to 4 quarters of funding at the recent spend rate as of its September 2026 quarter. No proposed securities issues are pending.
Quick answers · 4
When did PER last raise capital?
The last capital raise in Percheron Therapeutics's filings is Placement of $2.3M announced 1 Sept 2026, one of 2 cash raises in 24 months.
How much placement capacity does PER have left?
About 84% of the 15% placement capacity left, about 16% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How much cash does PER have?
In its quarterly cash report for the quarter ended 30 Sept 2026, Percheron Therapeutics reported $4.9M of cash and estimated 8.6 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do PER's options expire?
Unexercised options and rights equal 25.9% of Percheron Therapeutics's shares on issue; the nearest expiry is Apr 2028.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 14 Oct 2026 | 2A · quoted issue | PER : ORDINARY FULLY PAID | 1.96B | Appendix 2A |
| 14 Oct 2026 | 2A · quoted issue | PER : ORDINARY FULLY PAID | 1.84B | Appendix 2A |
| 8 Oct 2026 | 3G · unquoted | PER : ORDINARY FULLY PAID | 1.82B | Appendix 3G |
| 7 Sept 2026 | 2A · quoted issue | PER : ORDINARY FULLY PAID | 1.82B | Appendix 2A |
| 31 Aug 2026 | 3H · cancellation | PER : ORDINARY FULLY PAID | 1.52B | Appendix 3H |
Each filing states the count for the security it names, as at its own reference date and in the units of that filing — so the newest row (1.96B) need not equal the current count above (1.98B).
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
2 cash raises in the last 24 months · 2 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered439.3M · 22.2% of sharesOptions and warrants — they convert when the share price clears their exercise price.
- Condition-triggered75.0M · 3.8% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 439.3M priced, 75.0M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
At $0.0030 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 1.5× today’s price, which takes it to 8.1M (0.4% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 75.0M (14.6% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
- 136.2M more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| PERAQ | Options | Price-triggered | $0.010 | 15 Apr 2028 | 295.0M | Filing |
| PERAO | Options | Price-triggered | $0.035 | 20 May 2028 | 107.1M | Filing |
| PERAJ | Options | Price-triggered | $0.061 | 30 June 2028 | 3.0M | Filing |
| PERAI | Options | Price-triggered | $0.070 | 7 Aug 2028 | 5.0M | Filing |
| PERAK | Options | Price-triggered | $0.083 | 4 July 2029 | 9.0M | Filing |
| PERAL | Options | Price-triggered | $0.26 | 29 Nov 2029 | 4.0M | Filing |
| PERAM | Options | Price-triggered | $0.39 | 29 Nov 2029 | 4.0M | Filing |
| PERAN | Options | Price-triggered | $0.52 | 29 Nov 2029 | 4.0M | Filing |
| PERAB | Options | Price-triggered | $0.004 | 3 July 2031 | 8.1M | Filing |
| PERAR | — | Condition-triggered | — | — | 75.0M | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 15 Oct 2026 | Michael Baker | Buy placement | 20.0M | — | — | $100k | 3Y notice |
| 8 Oct 2026 | Michael Baker | Other incentive | 75.0M | — | — | — | 3Y notice |
| 31 Aug 2026 | James Garner | Sell | — | 1.7M | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.